You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 5, February 4, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Homocysteine, Folate, Vitamin B6, and Cardiovascular Disease

Kilmer S. McCully, MD

JAMA. 1998;279:392-393.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The importance of hyperhomocysteinemia in the pathogenesis of arteriosclerosis was first recognized by study of vascular pathology in children with homocystinuria caused by 2 different enzymatic abnormalities of homocysteine metabolism.1 Homocystinuria caused by deficiency of cystathionine synthase, a pyridoxal phosphate-dependent enzyme, is characterized by vascular abnormalities and frequent arterial and venous thromboses.2 In 1968 a 2-month-old boy with a rare form of homocystinuria caused by deficiency of methyltetrahydrofolate homocysteine methyl transferase, a cobalamin-dependent enzyme, was discovered to have rapidly progressive arteriosclerosis.1 Because of the different metabolic patterns caused by these 2 enzymatic abnormalities, it was suggested that homocysteine causes arteriosclerotic plaques by a direct effect on the cells and tissues of the arteries. A third enzyme abnormality leading to homocystinuria, deficiency of methylenetetrahydrofolate reductase, a folate-dependent enzyme, was found to cause arteriosclerotic plaques,3 also supporting the conclusion that homocysteine is atherogenic. This interpretation explains the origin . . . [Full Text of this Article]

From the Department of Veterans Affairs Medical Center, Providence, RI.


RELATED ARTICLE

Folate and Vitamin B6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women
Eric B. Rimm, Walter C. Willett, Frank B. Hu, Laura Sampson, Graham A. Colditz, JoAnn E. Manson, Charles Hennekens, and Meir J. Stampfer
JAMA. 1998;279(5):359-364.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Homocysteine, vitamins, and vascular disease prevention
McCully
Am. J. Clin. Nutr. 2007;86:1563S-1568S.
ABSTRACT | FULL TEXT  

Homocysteine Level and Coronary Artery Disease
Kazemi et al.
ANGIOLOGY 2006;57:9-14.
ABSTRACT  

Hyperhomocysteinemia, Enzyme Polymorphism and Thiobarbituric Acid Reactive System in Children with High Coronary Risk Family History
Szamosi et al.
J. Am. Coll. Nutr. 2004;23:386-390.
ABSTRACT | FULL TEXT  

Relationship of Dietary Folate and Vitamin B6 With Coronary Heart Disease in Women
Cleophas et al.
JAMA 1998;280:417-419.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.